This compound has an MDM2 binding affinity of IC50 = 4.8 nM, cell activity of IC50 < 100 nM in wt-p53 cancer cell lines, and it retains good plasma exposure, improved distribution, and in vivo complete tumor regression in a mouse xenograft model (Table 1) [44]. This evidence concerns the gene MDM2 and cancer.